Progyny Inc. Sets IPO at 10 Million Shares; Sees Pricing at $14-$16 Each

By Colin Kellaher

Progyny Inc., a benefits-management company backed by private-equity firm TPG Inc., on Tuesday said it expects to sell 6.7 million shares at $14 to $16 apiece in its initial public offering.

At the $15 midpoint of that range, the New York company focused on fertility and family-building benefits said it expects net proceeds of about $91 million.

Certain shareholders, including Germany's Merck KGaA (MRK.XE), are selling another 3.3 million shares in the IPO, for a total offering of 10 million shares, Progyny said.

Progyny will have about 82.2 million shares outstanding after the IPO, according to a filing with the Securities and Exchange Commission, for a market capitalization of roughly $1.23 billion at the $15-a-share midpoint.

TPG, which isn't selling any shares, will own about 25% of Progyny after the offering.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

October 15, 2019 11:22 ET (15:22 GMT)

Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Mar 2024 to Apr 2024